Leef Brands (LEEEF) Net Margin (2025 - 2026)
Leef Brands (LEEEF) reported Net Margin of 4.55% for Q1 2026, down 737.0% on a YoY basis from 0.71% in Q1 2025, and down 260.74% sequentially from 2.83% in Q1 2025.
Leef Brands (LEEEF) Net Margin (2025 - 2026) Analysis & Trends
Leef Brands (LEEEF) has 2 years of Net Margin data on file, last reported at 4.55% in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 9.29% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 26.57% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -33.66% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 35.18% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 5.03% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 24.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 4.16% |
| 10 | Leef Brands | 51.94 Mn | 46.18 Mn | 4.62 Mn | -4.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.55% |
| Mar 31, 2025 | 2.83% |